Clinical Trial Update: Efficacy of Ursodeoxycholic Acid (UDCA) in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy of ursodeoxycholic acid (UDCA) in patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: University of Banja Luka | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: UNKNOWN